Clinical trial Recruiting at 1 site Observational

Evaluating outcomes of Clareon Vivity lenses in patients with previous vision correction surgery

Official title: Clinical Outcomes of Bilateral Clareon Vivity in Post-Refractive Patients

Run by Utah Eye Centers · NCT06924944 · Data updated 2026-11-12

This study is testing how well Clareon Vivity lenses work for people with age-related cataracts who have previously had vision correction surgery like LASIK or PRK.

More Cataract Surgery trials

Quick facts

Study typeObservational
SexAll
Enrollment35 (estimated)
SponsorUtah Eye Centers
Academic / other
Locations1 site (Ogden, Utah)
StatusRecruiting
StartedJanuary 20, 2025
Main results expectedDecember 2025
Study endsApril 2026
Registry record updatedApril 13, 2025
Trial IDNCT06924944 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals with bilateral age-related cataracts who have previously undergone uncomplicated myopic refractive surgery and meet specific visual acuity criteria.

Probably not a fit

Patients with significant ocular or systemic comorbidities that could affect visual acuity or contrast sensitivity are unlikely to benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the clinical outcomes of patients who have undergone bilateral cataract surgery using Clareon Vivity intraocular lenses (IOLs) after having previous myopic refractive surgery, such as LASIK or PRK. The study focuses on patients with age-related cataracts who are otherwise healthy and have a history of uncomplicated refractive surgery. By analyzing visual acuity and other outcomes post-surgery, the study seeks to provide insights into the effectiveness of these lenses in achieving good vision at various distances. The research is based on data from an international registry and aims to address the challenges faced by post-refractive surgery patients in achieving predictable visual outcomes.

Why it matters

Potential benefit: If successful, this study could enhance the understanding of how Clareon Vivity lenses perform in patients with a history of refractive surgery, potentially leading to improved visual outcomes and greater spectacle independence.

How similar studies have gone: While this study builds on existing data regarding the effectiveness of Vivity IOLs, it specifically targets a unique patient population, making it a novel approach in this context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* o Bilateral age-related visually significant cataracts in otherwise healthy eyes, undergoing uncomplicated bilateral sequential Clareon Vivity IOLs

  * Prior history of uncomplicated post-refractive myopic surgery (LASIK/PRK) with up to 1 enhancement treatment
  * Potential acuity measured post-operatively 20/25 or better in both eyes
  * Patients with regular astigmatism that can be managed with T3 toric lens or arcuate incision

Exclusion Criteria:

* o Ocular or systemic comorbidities that may alter or reduce visual acuity and contrast sensitivity such as severe dry eye/ocular surface disease, glaucoma, macular degeneration, retinopathy, neuro-ophthalmic diseases, etc.

  * Prior ocular surgeries other than uncomplicated corneal refractive surgery and excluding RK
  * Patients with irregular astigmatism/topography (to rule out signs of potential ectasia), corneal dystrophies, and pupil abnormalities
  * Total HOA cutoff of ≤0.5, coma ≤0.3
  * RLE patients

Where it's running

  • Utah Eye Centers
    Ogden, Utah, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.